Clinical Trial Update: Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating valproic acid in patients with previously treated non-Hodgkin lymphoma, Hodgkin lymphoma, or chronic lymphocytic leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Auxilio Mutuo Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: UNKNOWN